Onderneming Cullinan Therapeutics, Inc.
Aandelen
CGEM
US2300311063
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
18,06 USD | +1,01% | +3,97% | +77,23% |
Vakgebied
Aantal werknemers: 85
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Nadim Ahmed
CEO | Chief Executive Officer | 56 | 18-10-21 |
Jeffrey Jones
CTO | Chief Tech/Sci/R&D Officer | 53 | 28-02-22 |
Jacquelyn Sumer
CMP | Compliance Officer | 46 | 15-08-22 |
Chief Tech/Sci/R&D Officer | 57 | 01-01-18 | |
Kevin Johnston
CTO | Chief Tech/Sci/R&D Officer | - | 01-05-22 |
Chad Messer
IRC | Investor Relations Contact | - | 01-03-22 |
Corinne Savill
PRN | Corporate Officer/Principal | 64 | 01-02-17 |
Stephen Andre
HRO | Human Resources Officer | 62 | 01-04-22 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chairman | 71 | 01-08-17 | |
Thomas Ebeling
BRD | Director/Board Member | 65 | 01-08-17 |
Stephen Webster
BRD | Director/Board Member | 63 | 01-09-20 |
Nadim Ahmed
CEO | Chief Executive Officer | 56 | 18-10-21 |
Director/Board Member | 52 | 28-02-22 | |
David Ryan
BRD | Director/Board Member | 57 | 01-11-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 43 065 645 | 40 310 790 ( 93,60 %) | 0 | 93,60 % |
Bedrijfsgegevens
Sector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+77,23% | 770 mln. | |
-1,82% | 41,36 mld. | |
+44,25% | 41,3 mld. | |
+2,56% | 39,61 mld. | |
-12,11% | 25,62 mld. | |
+3,09% | 24,09 mld. | |
-24,16% | 18,38 mld. | |
+22,12% | 11,85 mld. | |
-3,74% | 11,82 mld. | |
+7,75% | 11,07 mld. |
- Beurs
- Aandelen
- Koers CGEM
- Onderneming Cullinan Therapeutics, Inc.